Mesangeau
Christophe Mesangeau, Oxford, MS US
Patent application number | Description | Published |
---|---|---|
20100329978 | HIGHLY SELECTIVE SIGMA RECEPTOR LIGANDS - Compounds having the general formula II, III, or IV | 12-30-2010 |
20110280804 | HIGHLY SELECTIVE SIGMA RECEPTOR RADIOLIGANDS - Compounds having the general formula III′, or IV′ | 11-17-2011 |
20140315919 | HIGHLY SELECTIVE SIGMA RECEPTOR LIGANDS - A compound useful for treating subjects in need of therapy involving sigma receptors or for alleviation of affects resulting from drug abuse having the general formula I | 10-23-2014 |
20150018339 | HIGHLY SELECTIVE SIGMA RECEPTOR LIGANDS - Compounds having the general formula II, III, or IV | 01-15-2015 |
Christophe Mesangeau, Oxford FR
Patent application number | Description | Published |
---|---|---|
20110195955 | HIGHLY SELECTIVE SIGMA RECEPTOR LIGANDS - A compound useful for treating subjects in need of therapy involving sigma receptors or for alleviation of affects resulting from drug abuse having the general formula I | 08-11-2011 |
Christophe Mesangeau, Hellemmes FR
Patent application number | Description | Published |
---|---|---|
20140328755 | HIGHLY SELECTIVE SIGMA RECEPTOR LIGANDS AND RADIOLIGANDS AS PROBES IN NOCICEPTIVE PROCESSING AND THE PATHPHYSIOLOGICAL STUDY OF MEMORY DEFICITS AND COGNITIVE DISORDERS - A method for localizing and quantifying S1R role in nociceptive processing; for providing a guide to providing an analgesic therapy; of using an S1R selective ligand as a biomarker for pathphysiological study of memory deficits and cognitive disorders; or of detecting increased S1R density at the site of nerve injury arising from neuropathic pain comprising using as a probe at least one SR1 selective compound or radioligand of the general formula III′, or IV′: | 11-06-2014 |
Didier Mesangeau, Combs La Ville FR
Patent application number | Description | Published |
---|---|---|
20100158999 | COMBINATION OF TRIAZINE DERIVATIVES AND HMG-COA REDUCTASE INHIBITORS - The present patent application relates to combinations of a triazine derivative with an HMG-CoA reductase inhibitor. | 06-24-2010 |
20100159005 | COMBINATION OF TRIAZINE DERIVATIVES AND PPARalpha AGONISTS - The present patent application relates to combinations of triazine derivatives and of PPARα agonists. | 06-24-2010 |
20100233255 | COMBINATION OF TRAZINE DERIVATIVES AND INSULIN SECRETION STIMULATORS - The present patent application relates to novel combinations of a triazine derivative and of an insulin secretion stimulator. | 09-16-2010 |
20100285117 | COMBINATION OF TRIAZINE DERIVATIVES AND INSULIN SENSITISERS - The present invention relates to combinations of triazine derivatives and of insulin sensitisers. | 11-11-2010 |
20110306543 | COMBINATION OF INSULIN WITH TRIAZINE DERIVATIVES AND ITS USE FOR TREATING DIABETES - The invention relates to a composition for use as a medicament comprising insulin in combination with at least one compound of formula (I) | 12-15-2011 |
20120122873 | AMINO DERIVATIVES OF DIHYDRO-1,3,5-TRIAZINE USED IN THE TREATMENT OF ISCHEMIA AND/OR REPERFUSION RELATED DISEASES - The invention relates to amino derivatives of dihydro-1,3,5-triazine, used for the treatment and/or prevention of diseases induced by ischemia and/or reperfusion, notably cardiac and renal complications. | 05-17-2012 |
20130310312 | COMBINATION OF INSULIN WITH TRIAZINE DERIVATIVES AND ITS USE FOR TREATING DIABETES - The invention relates to a composition for use as a medicament comprising insulin in combination with at least one compound of formula (I) | 11-21-2013 |
20140050786 | COMBINATION OF TRIAZINE DERIVATIVES AND INSULIN SENSITISERS - The present invention relates to combinations of triazine derivatives and of insulin sensitisers. | 02-20-2014 |
Didier Mesangeau, Combx La Ville FR
Patent application number | Description | Published |
---|---|---|
20120115872 | COMBINATION OF A SODIUM-PROTON EXCHANGER INHIBITOR AND OF A DIHYDRO-1,3,5-TRIAZINE AMINE DERIVATIVE - The invention relates to a combination of a sodium-proton exchanger inhibitor and of a dihydro-1,3,5-triazine amine derivative which is useful for the treatment and/or prevention of pathologies induced by ischaemia and/or reperfusion, especially cardiac and renal complications. | 05-10-2012 |
Didire Mesangeau, Combs La Ville FR
Patent application number | Description | Published |
---|---|---|
20110236317 | TETRAHYDROTRIAZINE COMPOUNDS FOR TREATING DISEASES ASSOCIATED WITH AMPK ACITIVITY - The invention relates to compounds of formula (I) wherein the radicals R | 09-29-2011 |